A POST‐MARKETING SURVEILLANCE STUDY OF 703 PATIENTS TREATED WITH CHIDAMIDE FOR PERIPHERAL T‐CELL LYMPHOMA (PTCL) IN CHINA. HDAC STUDY GROUP OF UNION FOR CHINA LYMPHOMA INVESTIGATORS (UCLI). (June 2017) - Ma, J.; Zhu, J.; Shi, Y.K.; Huang, H.Q.; Jiang, W.Q.; Li, W.Y.; Wang, J.H.; Xu, W.; Hou, M.; Jin, Z.M.; Liu, T.; Liu, P.; et al.